ornithylaspartate has been researched along with Brain Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Fang, Z; Hui, L; Yu-E, Y; Zheng-Li, D; Zhi-Qin, L | 1 |
| Apperley, JF; Brett, SJ; Patel, A; Patel, PB; Rahemtulla, A; Waheed, U | 1 |
| Boveé, WM; Chamuleau, RA; Karlsen, OT; Mass, MA; Vogels, BA | 1 |
3 other study(ies) available for ornithylaspartate and Brain Diseases
| Article | Year |
|---|---|
Valproate-induced hyperammonemic encephalopathy treated by L-ornithine-L-aspartate: a case report.
Topics: Ammonia; Anticonvulsants; Brain Diseases; Humans; Male; Middle Aged; Valproic Acid | 2023 |
Rapid initial response of myeloma hyperammonemic encephalopathy to L-ornithine-L-aspartate and dexamethasone therapy.
Topics: Aged, 80 and over; Brain Diseases; Dexamethasone; Dipeptides; Drug Therapy, Combination; Humans; Hyperamylasemia; Male; Multiple Myeloma | 2014 |
L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats.
Topics: Ammonia; Analysis of Variance; Animals; Brain; Brain Diseases; Dipeptides; Drug Therapy, Combination; Magnetic Resonance Spectroscopy; Male; Microdialysis; Nitrogen; Ornithine; Portacaval Shunt, Surgical; Protons; Rats; Rats, Wistar; Synaptic Transmission | 1997 |